Falgagen has formed to offer consulting and advisory services regarding hyaluronic acid and chitosan, to assist life sciences companies in the conception and development of medical devices made of natural polymers.
The team of scientists and medical device strategists has strong expertise in viscoelastic solutions and gels, and can assist in refining a current formulation or developing new products as well as set up and improvement of industrial operations. Further, Falgagen can perform market analysis on behalf of clients, including negotiations for product in- and out-licensing, business planning and strategy.
“We are at the forefront of a new era in the medical device industry,” said Thomas Fevre, Managing Partner and Co-Founder at Falgagen. “Any market player involved in the marketing of hyaluronic acid- or chitosan-based products will have to embrace a much larger regulatory responsibility; these actors will have to quickly master technical competences on these molecules to continue innovating. We are here to support them integrating efficiently advanced experiences and competences.”
Source: Falgagen SAS